What does license — net product and licensing revenue mean?

This metric represents the total revenue generated from the sale of pharmaceutical products and the licensing of intellectual property within a specific business segment. It reflects the company's ability to monetize its drug portfolio through both direct commercial sales and strategic partnership agreements. Growth in this figure indicates successful market adoption and effective commercialization strategies.

Lexicon Pharmaceuticals LXRX License — Net product and licensing revenue

Similar metrics at other companies

STOKLicense — Revenue

$2.88M-60.9%

INTALicense — Total revenues

$24.79M-21.7%

ARDXLicensing revenue — Total revenues

$51K-99.0%

OTEXLicense — Total revenues

$145.09M+4.9%

ACIWLicense — Revenue

$88.04M+4.2%

RYTMLicense revenue — Total revenues

$0+100%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+262%

Enterprise value$976.73M+209%

P/S14.2×+5.4×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's license — net product and licensing revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's license — net product and licensing revenue?: Lexicon Pharmaceuticals (LXRX) reported license — net product and licensing revenue of $20M in Q1 2026.
What does license — net product and licensing revenue mean?: This metric represents the total revenue generated from the sale of pharmaceutical products and the licensing of intellectual property within a specific business segment. It reflects the company's ability to monetize its drug portfolio through both direct commercial sales and strategic partnership agreements. Growth in this figure indicates successful market adoption and effective commercialization strategies.